A Map of Ourselves  by unknown
Leading Edge
SelectAMap of Ourselves
When setting out through unknown territory, it is always wise to take a map. This is also true for
explorations in biology, even whenwe ourselves are the subject. In this Select, we highlight intrepid
mapmakers whose efforts to chart new realms of human biology will aid the discovery of new
cellular mechanisms and therapies for disease.3D mapping of a single transcript in the Allen Human Brain Atlas.
Courtesy of Allen Human Brain Atlas.Odyssey of the Mind
The human brain is arguably the most distinctive feature
of our species, and much study has been devoted to
understanding its inner workings and, specifically, the
variation that exists between individuals and between
closely related species. The same complexity that
endows us with the ability to write symphonies and
send robots to Mars, however, presents a daunting chal-
lenge to this line of research. A new study by Hawrylcz
et al. (2012) provides researchers with a much-needed
guide to the human brain by mapping the genome-
wide distribution of transcripts with exquisite anatomical
detail. The Allen Human Brain Atlas was generated from
two healthy male brains that were first subjected to
magnetic resonance imaging (MRI) and then laser micro-dissected into 900 anatomically distinct regions from which RNA was isolated for microarray analysis. Projecting
the gene expression data back onto the MRI coordinates creates a quantitative 3D map of the human brain tran-
scriptome. The study finds that the transcriptomes of the two brains are highly similar, consistent with other
evidence suggesting that the brain transcriptional network is quite robust. Hawrylcz and colleagues also note
that expression in the neocortex is more uniform than it is in other brain regions and speculate that this may be
a result of its relatively recent evolutionary expansion. Armed with this incredible resource, all scientists interested
in the brain, be it from a perspective of development, cognition, or disease, will be able to explore brain function (and
dysfunction) in much greater depth.
Hawrylycz, M., et al. (2012). Nature 489, 391–399.Epigenetic Timelines
Although it is widely accepted that epigenetic changes, such as DNA methylation, occur during our lifetimes, it is
unclear whether or not such changes are caused by environmental cues or are simply correlated with external events.
To begin to tease apart cause from consequence, Beyan et al. (2012) have developed a new method to determine
DNA methylomes from archived neonatal blood samples called Guthrie cards. The practice of storing a sample of
blood from newborns has been widespread for the past 20 years, providing the opportunity for both retrospective
and longitudinal studies. Beyan and colleagues identify in three individuals about a dozen differentially methylated
regions that were present at birth and remained stable for 3 years. They postulate that these differences are likely
the result of environmental factors in utero, such as maternal diet, although genetic variation is not entirely ruled
out. Larger-scale applications of Guthrie card methylomics in the future should be helpful in understanding the role
of epigenetics in complex diseases by creating a timeline of the modifications, which will provide information about
the causal nature of these changes. Ultimately, this type of study could be useful in early identification of disease
and the development of preventative treatments.
Beyan, H., et al. (2012). Genome Res. Published online August 23, 2012. http://dx.doi.org/10.1101/gr.134304.111.Cell 151, October 26, 2012 ª2012 Elsevier Inc. 461
Some of the twins enrolled in the TwinsUK
cohort, which was instrumental for this study.
Courtesy of TwinsUK photo archive.Following Parallel Lines
Genome-wide association studies aimed at detecting genetic variation
underlying complex diseases, such as type II diabetes and heart disease,
have identified many common variants. But in most instances, the causa-
tive variant remains elusive. Furthermore, the identified common variants
only account for a fraction of the heritability estimates of the disease. It
has been speculated that this missing heritability may be caused, in part,
by nongenetic or epigenetic effects or may be due to multiple rare variants.
Grundberg et al. (2012) tackle this issue through a large study of gene
expression in three tissue types derived from almost 400 pairs of twins.
By leveraging this unique population, they distinguish the contributions of
cis and trans genetic variation, as well as nongenetic variation to gene
expression changes. Interestingly, they find an important and previously
underappreciated role for trans variation in the regulation of expression
traits, much of which is tissue type specific. In addition, Grundberg andcolleagues find that more than 12% of the total heritability of a gene expression trait cannot be explained by common
cis variants. They suggest that part of the ‘‘missing heritability’’ is likely due to rare variants in cis and stress the impor-
tance of exome and whole-genome sequencing in the quest to identify loci causative of complex diseases. This map of
the cis and trans regulatory effects on gene expression levels highlights the need for deeper study of trans variation,
which will require even larger sample sizes and a focus on specific tissues to draw meaningful conclusions.
Grundberg, E., et al. (2012). Nat. Genet. 44, 1084–1089.lncRNAs play roles in both normal human cells and
cancer cells. Courtesy of Howard Y. Chang.Surveying the Dark Matter of Cancer
Long noncoding RNAs (lncRNAs) are joining the legions of factors
implicated in cancer. However, little is known about the global
involvement of this class of noncoding RNA in various cancer types.
Because lncRNA expression patterns generally exhibit a higher
degree of tissue specificity than protein coding genes, they may
make useful biomarkers to aid in cancer treatment. To assess this
possibility, Brunner et al. (2012) surveyed the expression of lncRNAs
using 30 end sequencing for expression quantification (3SEQ) in 64
tumor samples. They find a significant degree of cancer type speci-
ficity in the differential regulation of some of the lncRNAs, although
many of them are also expressed in normal cells, suggesting that
they are not binary indicators of cancer and that they may have func-
tions in normal cells. The 3SEQ method also allowed Brunner and
colleagues to identify more than a thousand novel transcripts in the
tumor samples. As a proof of principle, they characterize one such
novel transcript that is specific to epithelial breast cells and whose
expression is correlated with estrogen receptor expression, suggest-
ing that it may be a useful biomarker to classify breast cancer
subtypes. This comprehensive profile of lncRNA and novel transcript
expression levels will provide researchers with a wealth of tumor-specific data that will illuminate further study of the
role of these noncoding RNAs in cancer and may guide the development of new therapeutics.
Brunner, A., et al. (2012). GenomeBiol. Published online August 28, 2012. http://dx.doi.org/10.1186/gb-2012-13-8-r75.
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